Company Active LTD

Company profile

Ascend Technologies Limited

UK company 08700928, incorporated on 23 September 2013.

Ascend Technologies Limited

Ascend Technologies Limited is a UK company with status active founded in 2013 based in South East England.

Company number
08700928
Incorporated
23 Sep 2013
Companies House status
Active

Company identity

Founded / incorporated
23 September 2013

Company number 08700928

Verify at Companies House
Legal name
ASCEND TECHNOLOGIES LIMITED
Company type
LTD
Region
South East England
Registered address
Unknown
Insolvency history
No

Latest accounts

Financial period: 1 Oct 2023 to 30 Sep 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
2

Company events

Reference milestones and recent Companies House filing stream events.

2 events
25 Sep
2026

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzU0NzU3NjY4M2FkaXF6a2N4

Published 25 Sep 2026 08:56

23 Sep
2013

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2023
Funded years
2023, 2024
Age at first award
9 years

Projects

2024 EU-Funded Lead participant

Advanced nano encapsulation of bio-based pesticides and fertilisers for a circular and sustainable viticulture

1 Jun 2024 to 31 May 2028

Awarded
£478,331
Total cost £478,331

The main objective of the VINNY is the development of sustainable, low-cost nanoformulated biopesticides (nanoBPs) and biofertilizers (nanoBFs) for contributing to more resilient vineyard systems. The application of VINNY nanoformulations will allow contributing to the ultimate switch from intensive to sustainable agriculture in viticulture, on a global s...

2023 EU-Funded Lead participant

Photoacoustic imaging and artificial intelligence-based theranostic approach for cancer

1 Sep 2023 to 31 Aug 2026

Awarded
£327,046
Total cost £327,046

Health programs crave for diagnostic imaging and eradication of chemoresistant neoplastic lesions smaller than 1 mm of size. PHIRE, based on the outcomes from EDIT (FET-OPEN-RIA, GA#801126), aims at bringing closer to market a novel high-resolution theranostic medical device effective in the clinical applications for lesions <1 mm, ready for application i...

Product types

EU-Funded